Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates

This article was originally published on Nasdaq

Prothena (PRTA) came out with a quarterly loss of $1.03 per share versus the Zacks Consensus Estimate of a loss of $0.92. This compares to loss of $0.88 per share a year ago. These figures are adjusted for non-recurring items.